No trial date has been set for Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged infringement of U.S. Patent Nos. 5,912,013 and 5,326,570.
Both patents relate to carbamazepine.
The…
No trial date has been set for Shire Ltd.’s patent infringement suits against Barr, Mylan, Inc., Mylan Pharmaceuticals, Inc., and Matrix Laboratories, Inc., and Natco Pharma Limited.
In February 2009, Shire…
Pfizer Inc. is pursuing an appeal to the Canadian Federal Court in Toronto’s declaration that its amlodipine besylate patent is invalid.
Certain generic manufacturers are seeking to market generic amlodipine products…
The settlement of the patent infringement suit captioned “Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,” remains subject to review by the U.S. Federal Trade Commission.
In…
Pfizer Inc. said it will file an action in the Canadian Federal Court in Toronto to prevent approval of Genpharm Inc.’s proposed generic product.
In July 2009, Genpharm Inc. served notice…
A trial date has been set for April 5, 2010, on Forest Laboratories Inc.’s patent infringement complaint against generic manufacturers of Namenda, the Company’s N-methyl-D-aspartate.
During the third quarter of fiscal…
Pfizer Inc. pursues a patent infringement action against Matrix Laboratories Limited, Mylan Inc., and another subsidiary of Mylan.
In May 2009, Matrix, a subsidiary of Mylan, notified the Company that it…
Carnival Corp. and its subsidiaries and affiliates, and other unaffiliated cruise lines face an amended complaint in New York alleging copyright violations.
In January 2006, a lawsuit was filed against Carnival…
A trial on the patent infringement action captioned Infosint S.A. v. H. Lundbeck A/S, H. Lundbeck Inc. and Forest Laboratories, Inc., is scheduled to begin on Sept. 28, 2009.
In April…
Forest Laboratories Inc. and H. Lundbeck A/S face Caraco Pharmaceutical Laboratories, Ltd.’s declaratory judgment action for non-infringement of a third patent for Lexapro.
Lexapro was developed by the Company and Lundbeck,…